Markku Miettinen

Markku Miettinen

UNVERIFIED PROFILE

Are you Markku Miettinen?   Register this Author

Register author
Markku Miettinen

Markku Miettinen

Publications by authors named "Markku Miettinen"

Are you Markku Miettinen?   Register this Author

100Publications

2785Reads

49Profile Views

Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma.

J Thorac Oncol 2020 Mar 26;15(3):457-461. Epub 2019 Nov 26.

Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.11.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044061PMC
March 2020

Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies.

Pharmacol Ther 2019 09 23;201:94-102. Epub 2019 May 23.

Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2019.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708787PMC
September 2019

Epithelioid variant of gastrointestinal stromal tumor harboring PDGFRA mutation and MLH1 gene alteration: A case report.

Pathol Int 2019 Sep 4;69(9):541-546. Epub 2019 Jul 4.

Department of Experimental Pathology and Tumor Biology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12830DOI Listing
September 2019

Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors.

Mod Pathol 2019 07 13;32(7):957-966. Epub 2019 Feb 13.

Laboratory of Pathology, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0163-yDOI Listing
July 2019

Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma.

J Transl Med 2019 07 30;17(1):246. Epub 2019 Jul 30.

Division of Surgical Oncology, Department of Surgery, Moores Cancer Center, University of California, San Diego, UC San Diego Health Sciences, 3855 Health Sciences Drive, Room 2313, Mail Code 0987, La Jolla, CA, 92093-0987, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-019-1995-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668176PMC
July 2019

NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum.

Mod Pathol 2019 06 5;32(6):764-773. Epub 2019 Feb 5.

Department of Pathology, University of Nebraska Medical Center, Omaha, NE, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0206-zDOI Listing
June 2019

Variable somatostatin receptor subtype expression in 151 primary pheochromocytomas and paragangliomas.

Hum Pathol 2019 04 8;86:66-75. Epub 2018 Dec 8.

Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki FIN-00014, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.11.020DOI Listing
April 2019

New fusion sarcomas: histopathology and clinical significance of selected entities.

Hum Pathol 2019 04 8;86:57-65. Epub 2019 Jan 8.

Laboratory of Pathology, National Cancer Institute, Bethesda 20892, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.12.006DOI Listing
April 2019

Gallbladder Paraganglioma Associated with Mutation: a Potential Pitfall on F-FDOPA PET Imaging.

Nucl Med Mol Imaging 2019 Apr 19;53(2):144-147. Epub 2019 Feb 19.

2Section on Medical Neuroendocrinology, Developmental Endocrine Oncology and Genetics Affinity Group, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Dr. MSC-1109, Bldg. 10, CRC, 1E-3140, Bethesda, MD 20892 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13139-018-0558-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473097PMC
April 2019

New Mechanisms of mTOR Pathway Activation in KIT-mutant Malignant GISTs.

Appl Immunohistochem Mol Morphol 2019 01;27(1):54-58

Laboratory of Pathology, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000541DOI Listing
January 2019

Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.

J Bone Miner Res 2019 01 14;34(1):145-156. Epub 2018 Sep 14.

Clinical and Investigative Orthopedics Surgery Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jbmr.3577
Publisher Site
http://dx.doi.org/10.1002/jbmr.3577DOI Listing
January 2019

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2018 05 18;36(13):1343-1373. Epub 2018 Jan 18.

Hedy L. Kindler and Samuel G. Armato III, The University of Chicago, Chicago, IL; Nofisat Ismaila, American Society of Clinical Oncology; Mary Hesdorffer, Mesothelioma Applied Research Foundation, Alexandria, VA; Raphael Bueno, Harvard Medical School, Boston, MA; Thierry Jahan, University of California San Francisco, San Francisco, CA; Clyde Michael Jones, Baptist Cancer Center Physicians Foundation, Memphis, TN; Markku Miettinen, Anish Thomas and Raffit Hassan, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Harvey Pass and Daniel Sterman, New York University Langone Medical Center; and Andreas Rimner and Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.6394
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.6394DOI Listing
May 2018

Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 2-Uncommon Sarcomas.

Radiographics 2017 May-Jun;37(3):797-812

From the Department of Radiology, Medstar Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC 20007 (A.D.L., M.A.M.); the American Institute for Radiologic Pathology, Silver Spring, Md (M.A.M.); and the Center of Cancer Research, National Cancer Institute, Bethesda, Md (M.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.2017160201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452890PMC
November 2017

N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.

J Clin Endocrinol Metab 2017 11;102(11):3990-4000

Translational Cancer Biology, Research Programs Unit, University of Helsinki, FIN-00014 University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2017-00401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283447PMC
November 2017

Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 1-Common Sarcomas: From the Radiologic Pathology Archives.

Radiographics 2017 Mar-Apr;37(2):462-483

From the Departments of Radiology (A.D.L., M.A.M.) and Surgery (W.B.A.), Medstar Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC 20007; the American Institute for Radiologic Pathology, Silver Spring, Md (M.A.M.); and the Center for Cancer Research, National Cancer Institute, Bethesda, Md (M.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.2017160157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416744PMC
October 2017

KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis.

Nat Med 2017 Oct 18;23(10):1176-1190. Epub 2017 Sep 18.

Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.4400DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724390PMC
October 2017

Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status.

PLoS One 2017 5;12(10):e0175484. Epub 2017 Oct 5.

Division of Hematology and Oncology, Department of Medicine, Columbia University, New York and James J. Peters VA Medical Center, Bronx, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0175484PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628783PMC
October 2017

Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future.

J Natl Cancer Inst 2017 08;109(8)

Rare Tumor Initiative, Laboratory of Pathology, and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC; Department of Neurology, Johns Hopkins Hospital, Baltimore, MD; Neurofibromatosis Center, Department of Neurology Guy's Hospital London, London, UK; Department of Neurology, Washington University School of Medicine, St. Louis, MO; Department of Human Genetics, University of Leuven, Leuven, Belgium; Hunstman Cancer Institute, University of Utah, Salt Lake City, UT; Division of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital, University of Cincinnati, Cincinnati, OH; Bill and Melinda Gates Foundation, Seattle, WA; Children's Tumor Foundation, New York, NY; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057517PMC
August 2017

Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer.

BMC Cancer 2017 Jul 21;17(1):495. Epub 2017 Jul 21.

Thoracic and Gastrointestinal Oncology Branch, Gastrointestinal Oncology Section, Investigator Center for Cancer Research, National Cancer Institute, Building 10 - Hatfield CRC, Room 4-5950, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3481-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522593PMC
July 2017

Oncogenic Activation of the Wnt/β-Catenin Signaling Pathway in Signet Ring Stromal Cell Tumor of the Ovary.

Appl Immunohistochem Mol Morphol 2016 May-Jun;24(5):e28-33

Departments of *Surgical Pathology †Molecular Diagnostic §Chemotherapy, Holycross Cancer Centre ∥Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland ‡Laboratory of Pathology, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000271DOI Listing
May 2017

GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.

Am J Surg Pathol 2017 May;41(5):577-585

*Laboratory of Pathology, National Cancer Institute, Bethesda, MD †Aichi Medical University School of Medicine, Nagakute, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000807DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391299PMC
May 2017

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies.

Sarcoma 2017 16;2017:7429697. Epub 2017 May 16.

National Cancer Institute, Pediatric Oncology Branch, 10 Center Drive, Room 1-3742, Building 10, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/7429697DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448069PMC
May 2017

PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma.

J Pathol 2017 04 1;241(5):626-637. Epub 2017 Mar 1.

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4867DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357165PMC
April 2017

SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma.

Arch Pathol Lab Med 2017 Apr 28;141(4):564-568. Epub 2017 Feb 28.

From the Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland (Drs Lasota, Felisiak-Golabek, Inaguma, Wang, and Miettinen); the Departments of Molecular Diagnostics (Dr Kowalik, Ms Pięciak, and Mr Zięba), Surgical Pathology (Dr Kopczynski), and Clinical Oncology (Dr Gozdz), Holycross Cancer Center, Kielce, Poland; the Department of Pathology, Aichi Medical University School of Medicine, Nagakute, Japan (Dr Inaguma); the Department of Pathomorphology, Medical University of Gdansk, Poland (Drs Pęksa and Biernat); the Department of Pathomorphology, Jagiellonian University, Krakow, Poland (Dr Okoń); ZDUNOMED/Histopathology, Szczecin, Poland (Dr Waloszczyk); and Faculty of Health Sciences, The Jan Kochanowski University, Kielce, Poland (Dr Gozdz). Drs Lasota and Kowalik contributed equally to this work.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0147-OADOI Listing
April 2017

Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas.

Mod Pathol 2017 02 4;30(2):278-285. Epub 2016 Nov 4.

Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2016.185DOI Listing
February 2017

Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases.

Am J Surg Pathol 2016 12;40(12):1661-1669

*Laboratory of Pathology, NCI/NIH, Bethesda, MD †Department of Biology and Genetics, Medical University of Gdansk, Gdansk, Poland ‡HusLab and University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000703DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106328PMC
December 2016

Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.

Lung Cancer 2016 11 28;101:104-110. Epub 2016 Sep 28.

Thoracic and Gastrointestinal Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.09.015DOI Listing
November 2016

Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors.

Am J Surg Pathol 2016 08;40(8):1133-42

*Laboratory of Pathology, National Cancer Institute, Bethesda, MD §Department of Pathology, Cell Biology and Anatomy, Jefferson Medical College of Thomas Jefferson University and University Hospital, Philadelphia, PA †Department of Pathology, Aichi Medical University School of Medicine, Nagakute, Japan ‡Department of Pathology/Haartman Institute and HusLab, Helsinki University Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000653DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942373PMC
August 2016

MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases.

J Immunother 2016 May;39(4):181-7

*Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN †Laboratory of Pathology ‡Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831141PMC
May 2016

Medallion-Like Dermal Dendrocytic Hamartoma, Dermatofibrosarcoma Protuberans, and Adenosine Deaminase-Deficient Severe Combined Immunodeficiency.

Pediatr Dermatol 2016 May;33(3):359-60

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pde.12847DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868401PMC
May 2016

Carney triad can be (rarely) associated with germline succinate dehydrogenase defects.

Eur J Hum Genet 2016 Apr 15;24(4):569-73. Epub 2015 Jul 15.

Section on Endocrinology and Genetics (SEGEN), Program on Developmental Endocrinology and Genetics (PDEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2015.142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929866PMC
April 2016

[Succinate dehydrogenase-deficient tumors--a novel mechanism of tumor formation].

Authors:
Markku Miettinen

Duodecim 2015 ;131(22):2149-56

View Article

Download full-text PDF

Source
February 2016

Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature.

Head Neck Pathol 2015 Jun 21;9(2):181-95. Epub 2014 Aug 21.

Woodland Hills Medical Center, Department of Pathology, Southern California Permanente Medical Group, 5601 De Soto Avenue, Woodland Hills, CA, 91365, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12105-014-0560-6
Publisher Site
http://dx.doi.org/10.1007/s12105-014-0560-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424207PMC
June 2015

Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.

Am J Surg Pathol 2015 Jun;39(6):826-35

*Laboratory of Pathology, NCI/NIH, Bethesda #Joint Pathology Center of the Capital Region, Silver Spring, MD †Department of Pathology, Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA ¶Southern California Permanente Medical Group, Woodland Hills, CA ‡University of Helsinki and HUSLab/Pathology, Helsinki, Finland §Department of Pathology, Medical University of Gdansk, Gdansk ∥Holy Cross Cancer Center, Kielce, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000398DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431945PMC
June 2015

CD30 expression in malignant vascular tumors and its diagnostic and clinical implications: a study of 146 cases.

Appl Immunohistochem Mol Morphol 2014 May-Jun;22(5):358-62

Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017247PMC
April 2015

Intranodal palisaded myofibroblastoma: another mesenchymal neoplasm with CTNNB1 (β-catenin gene) mutations: clinicopathologic, immunohistochemical, and molecular genetic study of 18 cases.

Am J Surg Pathol 2015 Feb;39(2):197-205

*Department of Pathology, Northwestern University, Chicago, IL †Laboratory of Pathology, National Cancer Institute (NCI), Bethesda ‡Department of Soft Tissue Pathology, Joint Pathology Center, Silver Spring, MD.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000299DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293230PMC
February 2015

Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.

Am J Surg Pathol 2014 Dec;38(12):1588-602

*Department of Anatomical Pathology †Cancer Diagnosis and Pathology Research Group §§Cancer Genetics, Kolling Institute of Medical Research, Royal North Shore Hospital ‡University of Sydney, Sydney ††Histopath Pathology ¶¶Douglass Hanly Moir Pathology, North Ryde ‡‡Department of Anatomical Pathology, St Vincents Hospital, Darlinghurst §§§Department of Anatomical Pathology, South Western Area Pathology Service, Liverpool, NSW ∥∥Pathology Queensland, Gold Coast University Hospital, Qld ****Department of Anatomical Pathology, Royal Children's Hospital, Parkville, Vic., Australia §Department of Pathology, Medical Faculty and Charles University, Pilsen, Czech Republic ∥Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Centre, Rotterdam ##Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands ¶Department of Pathology, Singapore General Hospital, Singapore, Singapore #Institute of Pathology, Friedrich-Alexander-University, Erlangen, Germany **Department of Pathology, Oslo University Hospital ***Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway †††Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH ¶¶¶Department of Pathology, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI ††††Laboratory of Surgical Pathology, National Cancer Institute, Bethesda, MD ‡‡‡Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada ∥∥∥Department of Pathology, Hopital Cochin Université Paris Descartes, Paris, France ###Department of Molecular Pathology, University of Dundee, Ninewells Hospital, Dundee, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000292DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229399PMC
December 2014

Clinicopathologic features of a second patient with Ewing-like sarcoma harboring CIC-FOXO4 gene fusion.

Am J Surg Pathol 2014 Dec;38(12):1724-5

*Department of Pathology, University of California, San Francisco San Francisco, CA †Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY ‡Genetics Branch §Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229425PMC
December 2014

Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach.

Am J Surg Pathol 2014 Sep;38(9):1235-41

*Laboratory of Pathology, National Cancer Institute (NCI), Bethesda, MD Departments of †Molecular Diagnostics §Surgical Pathology ∥Department of Clinical Oncology, Holycross Cancer Center ¶Faculty of Health Sciences, The Jan Kochanowski University, Kielce ‡Department of Biology and Genetics, Medical University of Gdansk, Gdansk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134735PMC
September 2014

Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.

Int J Biochem Cell Biol 2014 Aug 2;53:514-9. Epub 2014 Jun 2.

Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biocel.2014.05.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112081PMC
August 2014

Rare cancers.

Int J Biochem Cell Biol 2014 Aug 4;53:461. Epub 2014 Jun 4.

National Cancer Institute, Bethesda, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biocel.2014.06.001DOI Listing
August 2014

Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.

J Thorac Oncol 2014 Apr;9(4):567-71

*Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; †Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and ‡Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705182PMC
April 2014

Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases.

Head Neck Pathol 2014 Mar 15;8(1):88-109. Epub 2013 Sep 15.

Department of Pathology, Southern California Permanente Medical Group, Woodland Hills Medical Center, 5601 De Soto Avenue, Woodland Hills, CA, 91365, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12105-013-0487-3
Publisher Site
http://dx.doi.org/10.1007/s12105-013-0487-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950387PMC
March 2014

SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases.

Am J Surg Pathol 2014 Mar;38(3):410-20

*Laboratory of Pathology, National Cancer Institute, Bethesda, MD †Department of Pathology, Cell Biology and Anatomy, Jefferson Medical College of Thomas Jefferson University and University Hospital, Philadelphia, PA ‡Department of Pathology/Haartman Institute and HusLab, Helsinki University Hospital, Helsinki, Finland §Department of Tumor Pathology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Krakow ∥Department of Pathomorphology, Medical University of Gdansk, Gdansk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041084PMC
March 2014

Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms.

Appl Immunohistochem Mol Morphol 2014 Jan;22(1):31-6

*Laboratory of Surgical Pathology, National Cancer Institute, Bethesda, MD †Department of Pathology/Haartman Institute and HusLab, Helsinki University Hospital, Helsinki, Finland ‡Department of Pathology and Cell Biology, Jefferson Medical College of Thomas Jefferson University and University Hospital, Philadelphia, PA §Department of Pathomorphology, Medical University of Gdansk, Gdansk ∥Department of Pathology, National Tuberculosis and Lung Diseases Research Institute, Warsaw ¶Independent Laboratory of Pathology, Zdunomed, Szczecin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e31828bfdd3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714362PMC
January 2014

Immunohistochemistry of soft tissue tumours - review with emphasis on 10 markers.

Authors:
Markku Miettinen

Histopathology 2014 Jan 28;64(1):101-18. Epub 2013 Nov 28.

Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12298DOI Listing
January 2014

Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome.

Am J Surg Pathol 2014 Jan;38(1):1-12

*Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL †Department of Soft Tissue Pathology, Joint Pathology Center, Silver Spring ‡Laboratory of Pathology, National Institutes of Health/National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31829f3d85DOI Listing
January 2014

GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.

Am J Surg Pathol 2014 Jan;38(1):13-22

*Laboratory of Surgical Pathology, National Cancer Institute, Bethesda, MD †Department of Pathology, Cell Biology and Anatomy, Jefferson Medical College of Thomas Jefferson University and University Hospital, Philadelphia, PA ‡Department of Pathology/Haartman Institute and HusLab, Helsinki University Hospital, Helsinki, Finland §Department of Tumor Pathology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Krakow Branch ∥Department of Pathomorphology, Medical University of Gdansk, Gdansk ¶Department of Pathology, National Tuberculosis and Lung Diseases Research Institute, Warsaw #Independent Laboratory of Pathology, Zdunomed, Szczecin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3182a0218fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991431PMC
January 2014

Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis.

Authors:
Markku Miettinen

Mod Pathol 2014 Jan;27 Suppl 1:S17-29

National Cancer Institute, Laboratory of Pathology, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.178DOI Listing
January 2014

Frequent truncating mutations of STAG2 in bladder cancer.

Nat Genet 2013 Dec 13;45(12):1428-30. Epub 2013 Oct 13.

1] Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC, USA. [2] Department of Pathology, University of California, San Francisco, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2800DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875130PMC
December 2013

No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases.

Mod Pathol 2013 Nov 24;26(11):1488-91. Epub 2013 May 24.

Laboratory of Pathology, National Cancer Institute (NCI), Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.89DOI Listing
November 2013

ERG expression in epithelioid sarcoma: a diagnostic pitfall.

Am J Surg Pathol 2013 Oct;37(10):1580-5

*Laboratory of Pathology, National Cancer Institute, Bethesda ‡Joint Pathology Center, Silver Spring, MD †HUSLab, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31828de23aDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772974PMC
October 2013

Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression.

Sci Transl Med 2013 Oct;5(208):208ra147

Laboratory of Molecular Biology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3006941DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369691PMC
October 2013

When Benign Tumors Mimic Malignancies: A Case of Lymphangiomatosis Masquerading as Metastatic Disease.

Rare Cancers Ther 2013;1:21-27. Epub 2013 Sep 28.

Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903 USA ; Division of Medical Oncology, Department of Medicine, Rutgers University-Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40487-013-0001-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837931PMC
September 2013

Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients.

Am J Surg Pathol 2013 Sep;37(9):1365-72

*Laboratory of Pathology, National Cancer Institute, National Institutes of Health †National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases ‡National Institutes of Health, National Cancer Institute §National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e318297427dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787986PMC
September 2013

Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas.

Am J Surg Pathol 2013 Sep;37(9):1357-64

*Laboratory of Pathology †Pediatric Oncology Branch, NCI, NIH, Bethesda ‡Department of Pathology, Division of Neuropathology, Johns Hopkins Hospital, Baltimore, MD §Children's National Medical Center, Research Center for Genetic Medicine, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e318294e817DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787318PMC
September 2013

Gastrointestinal stromal tumors.

Gastroenterol Clin North Am 2013 Jun 13;42(2):399-415. Epub 2013 Mar 13.

Laboratory of Pathology, NCI/NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gtc.2013.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644178PMC
June 2013

NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target.

Oncoimmunology 2012 Nov;1(8):1409-1410

Laboratory of Pathology; National Cancer Institute; NIH; Bethesda, MD USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.21059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518519PMC
November 2012

Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors: a diagnostic pitfall.

Am J Surg Pathol 2012 Sep;36(9):1404-9

Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3182556defDOI Listing
September 2012

[Gastrointestinal stromal tumor].

Authors:
Markku Miettinen

Duodecim 2012 ;128(14):1441-50

Laboratory of Pathology National Cancer Institute/NIH, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
September 2012

A simple method for generating multitissue blocks without special equipment.

Authors:
Markku Miettinen

Appl Immunohistochem Mol Morphol 2012 Jul;20(4):410-2

Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e318245c82fDOI Listing
July 2012